Related Experiment Video
Updated: Oct 8, 2025

A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats
Published on: May 22, 2019
Serum Growth Differentiation Factor 15 Levels Are Associated With Depression After Ischemic Stroke
Yuhan Zang1, Zhengbao Zhu1,2, Yi Xie1
1Department of Epidemiology School of Public Health and Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases Medical College of Soochow University Suzhou China.
Insights
Elevated serum growth differentiation factor 15 (GDF-15) is linked to a higher risk of poststroke depression (PSD) within three months after ischemic stroke. GDF-15 may serve as a key biomarker for predicting PSD development.
Area of Science:
- Neurology
- Biomarkers
- Psychiatry
Background:
- The relationship between serum growth differentiation factor 15 (GDF-15) and poststroke depression (PSD) is not well understood.
- Investigating GDF-15's role is crucial for understanding depression after ischemic stroke.
Purpose of the Study:
- To examine the association between serum GDF-15 levels and the incidence of PSD in patients following ischemic stroke.
- To determine if GDF-15 can serve as a prognostic biomarker for PSD.
Main Methods:
- Analysis of a random sample of 572 patients from the China Antihypertensive Trial in Acute Ischemic Stroke (CATIS).
- Serum GDF-15 levels were measured, and depression was assessed using the Hamilton Depression Rating Scale (score ≥8) at 3 months post-stroke.
- Multivariate logistic regression was used to analyze the association between GDF-15 and PSD.
Main Results:
- Poststroke depression (PSD) occurred in 40.4% of patients (231 out of 572) within 3 months.
- The highest tertile of serum GDF-15 was associated with a significantly increased odds ratio for PSD (2.92; 95% CI, 1.36-6.27) compared to the lowest tertile.
- A linear association was observed between serum GDF-15 levels and the risk of PSD (P for linearity=0.006), with each SD increase in log-transformed GDF-15 linked to a 42% increased risk.
Conclusions:
- Elevated serum GDF-15 levels during the acute phase of ischemic stroke are independently associated with an increased risk of developing PSD.
- Serum GDF-15 shows potential as a valuable prognostic biomarker for identifying patients at risk of poststroke depression.
Abstract:
Background The effect of serum growth differentiation factor 15 (GDF-15) on poststroke depression (PSD) remains unknown. This study aimed to investigate the association between serum GDF-15 and PSD among patients with ischemic stroke. Methods and Results This study was based on a random sample from CATIS (China Antihypertensive Trial in Acute Ischemic Stroke). A total of 572 patients from 7 participating hospitals with GDF-15 levels were included in this analysis. The study outcome was depression (Hamilton Depression Rating Scale score ≥8) at 3 months after ischemic stroke. A total of 231 (40.4%) patients with stroke experienced PSD within 3 months. The multivariate-adjusted odds ratio of PSD associated with the highest tertile of serum GDF-15 was 2.92 (95% CI, 1.36-6.27) compared with the lowest tertile. Each SD increase in log-transformed GDF-15 was associated with a 42% (95% CI, 2%-97%) increased risk of PSD, and a linear association between serum GDF-15 and the risk of PSD was observed (P for linearity=0.006). Conclusions Elevated serum GDF-15 levels in the acute phase of ischemic stroke were independently associated with PSD, suggesting that GDF-15 may be a valuable prognostic biomarker for PSD.
Related Concept Videos
Depressive Disorders: MDD and Dysthymia
Depression: Overview
Long-term Depression
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...

